Examkin

Tüm alıştırma soruları

8270 soru

Tüm türler8,270Çoktan seçmeli4,249Çoklu seçim325Sayısal160Eşleştirme1,849Sıralama1,687
Soru 4161Soru →

A 53-year-old woman comes to the physician for a routine health maintenance visit. She has a history of hypertension that is well-controlled with hydrochlorothiazide. She does not smoke tobacco or use illicit drugs, and she drinks alcohol occasionally. She went through menopause at age 51 and has not had any vaginal bleeding or spotting since. Her body mass index is 24 kg/m², and her blood pressure is 122/76 mmHg.

A review of her medical records reveals the following:
- Mammogram 1 year ago: normal
- Colonoscopy 3 years ago (at age 50): normal
- Cervical cytology and human papillomavirus (HPV) co-testing 3 years ago: normal
- Fasting blood glucose 6 months ago: 88 mg/dL
- Lipid panel 1 year ago: normal
- HIV antibody test 5 years ago: negative
- Patient Health Questionnaire-2 (PHQ-2) today: negative

She received a Tdap booster 3 years ago. She has never been tested for hepatitis C.

Which of the following is the most appropriate next step in the preventive care of this patient?

Cevabı ve açıklamayı göster

Cevap: Hepatitis C virus antibody testing

Cevap

Hepatitis C virus antibody testing
Hepatitis C virus (HCV) antibody testing is recommended as a one-time routine screening for all adults aged 18 to 79 years. Because this patient has never had this screening, offering it is the most appropriate next step in her preventive care.

Adım Adım Çözüm

1
Evaluate the patient's age and demographic risk profile.
The patient is a 53-year-old female with an average-risk profile and no high-risk behaviors or symptoms.
Patient age and specific risk factors determine the appropriate baseline screening requirements according to USPSTF guidelines.
2
Review the patient's prior screening history to identify current gaps.
Recent mammogram, colonoscopy, Pap/HPV co-test, and HIV test are all up to date. She has never had HCV screening.
Careful chart review prevents redundant testing and identifies missing critical interventions.
3
Apply current USPSTF screening guidelines to the identified gaps.
One-time HCV screening is recommended for all adults aged 18 to 79. The patient qualifies for this test today.
To select the most appropriate next step in preventive care for this specific patient visit.

Anahtar Kavram

The USPSTF recommends one-time screening for hepatitis C virus (HCV) infection in all asymptomatic adults aged 18 to 79 years, regardless of risk factors.
Soru 4162Soru →

A 72-year-old man is evaluated in the emergency department for severe, tearing pain in his lower back and abdomen that started suddenly 45 minutes ago. His medical history includes hypertension, tobacco use disorder, and a 5.0-cm abdominal aortic aneurysm (AAA) discovered incidentally on an ultrasound six months prior. On physical examination, he is lethargic, pale, and profusely diaphoretic. His temperature is 36.5°C (97.7°F), blood pressure is 75/45 mmHg, pulse is 132/min, and respiratory rate is 24/min. Abdominal palpation reveals significant distension, diffuse tenderness with involuntary guarding, and a prominent, expansile periumbilical mass. The patient lacks decision-making capacity due to his lethargic state. His son, who holds a legally executed durable power of attorney for healthcare for the patient, urges the medical team to proceed with all necessary life-saving measures. Concurrently, the patient's estranged wife arrives and insists that no surgical interventions be performed. Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Immediate transfer to the operating room for surgical repair

Cevap

Immediate transfer to the operating room for surgical repair
The patient is presenting with the classic triad of a ruptured abdominal aortic aneurysm (AAA): severe tearing pain, a pulsatile abdominal mass, and profound hemodynamic instability (hypotension, tachycardia). In a hemodynamically unstable patient with a known AAA who presents with signs of rupture, the most appropriate next step is immediate transfer to the operating room for emergent surgical repair (open or endovascular). Delaying for advanced imaging is contraindicated because the patient can rapidly exsanguinate. Additionally, because the patient lacks capacity, consent is dictated by his legally appointed healthcare proxy (his son), whose medical authority legally supersedes that of the next-of-kin (his estranged wife). Therefore, no ethics delay is warranted.

Adım Adım Çözüm

1
Identify the underlying clinical syndrome.
The patient presents with the classic triad of a ruptured AAA: severe tearing pain, an expansile pulsatile abdominal mass, and profound hypotension.
Recognizing the diagnostic triad in the context of a known 5.0-cm AAA establishes the immediate etiology of his shock as catastrophic hemorrhage.
2
Assess hemodynamic stability to guide diagnostic/therapeutic workflow.
The patient is in class IV hypovolemic shock (BP 75/45 mmHg, HR 132/min, lethargy).
Hemodynamic instability dictates that the patient must not leave the monitored resuscitation area for advanced imaging (e.g., CT scan) and requires immediate intervention.
3
Determine the legal decision-maker to obtain consent.
The patient's son is the legally appointed healthcare proxy via a durable power of attorney.
A designated healthcare proxy overrides default state-mandated next-of-kin hierarchies (such as a spouse). The son's request for life-saving measures provides the necessary legal consent to proceed immediately to the operating room.

Anahtar Kavram

Management of hemodynamically unstable ruptured abdominal aortic aneurysm and proxy consent
Soru 4163Soru →

A 34-year-old right-handed male presents to the emergency department one hour after an altercation in which he was struck on the right upper arm with a heavy steel pipe. He complains of intense pain and an inability to use his right hand. His vital signs are within normal limits. On physical examination, the right arm reveals significant soft tissue swelling, ecchymosis, and a visible deformity over the mid-humerus. The skin is completely intact. Neurological examination of the right upper extremity reveals an inability to extend the wrist or fingers. Sensation to pinprick is diminished over the dorsal aspect of the first web space. The radial and ulnar pulses are 2+2+ and symmetric. Capillary refill is less than 22 seconds in all digits. Anteroposterior and lateral radiographs of the right humerus demonstrate a displaced transverse fracture of the middle third of the humeral shaft. Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Application of a coaptation splint and clinical observation

Cevap

Application of a coaptation splint and clinical observation
The clinical presentation is consistent with a closed midshaft humeral fracture complicated by a primary radial nerve palsy. The radial nerve courses through the spiral groove on the posterior aspect of the humerus, making it uniquely vulnerable to midshaft fractures. This injury results in weakness of wrist and finger extension (wrist drop) and sensory loss over the dorsal first web space. In the setting of a closed fracture, this is almost always a neurapraxia (stretch injury) rather than nerve transection. Because >90%>90\% of these palsies recover spontaneously within 3 to 4 months, the standard of care is conservative management. This involves immobilizing the fracture with a coaptation splint (or functional brace) and scheduling close outpatient follow-up to monitor for clinical signs of nerve recovery. Surgical exploration is generally reserved for open fractures, associated vascular injuries requiring repair, or a secondary nerve palsy (a deficit that appears only after a closed reduction attempt, suggesting the nerve has become entrapped in the fracture site).

Adım Adım Çözüm

1
Identify the primary injury from the physical exam and radiographic findings.
The patient has a closed, displaced transverse fracture of the midshaft humerus.
Establishing the correct anatomical fracture pattern is necessary to anticipate common complications.
2
Analyze the neurological deficits to identify the specific nerve involved.
Inability to extend the wrist/fingers and numbness in the first dorsal web space indicate a radial nerve palsy.
The radial nerve runs along the spiral groove of the mid-humerus, making it highly susceptible to injury in midshaft fractures.
3
Determine the appropriate management for a primary radial nerve palsy in a closed humeral shaft fracture.
Conservative management with a splint is chosen.
Primary radial nerve palsies in closed fractures are almost always neurapraxias that resolve spontaneously in >90%>90\% of cases. Immediate surgery is contraindicated unless specific criteria are met.

Anahtar Kavram

Primary radial nerve palsy in the setting of a closed humeral shaft fracture does not require immediate surgical exploration. Initial management is conservative with immobilization (e.g., coaptation splint) and clinical observation.
Soru 4164Soru →

A 25-year-old male is admitted to the neurosurgical intensive care unit following a severe traumatic brain injury sustained in a motor vehicle collision. He is intubated, mechanically ventilated, and receiving continuous infusions of propofol and fentanyl for sedation and analgesia. An intracranial pressure (ICP) monitor is in place. His ICP acutely rises to 28 mm Hg and remains elevated for 10 minutes despite the current sedation. His vital signs show a blood pressure of 130/80 mm Hg, heart rate of 85/min, and temperature of 37.2°C (99.0°F). Arrange the following interventions in the most appropriate stepwise sequence for managing this patient's elevated intracranial pressure, proceeding from initial, least invasive measures to final salvage therapy.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence for managing elevated ICP progresses from basic positioning, to osmotic therapy, to temporizing hyperventilation, and finally to salvage surgical decompression.
The management of elevated intracranial pressure (ICP) follows a stepwise algorithm to balance efficacy with the risk of secondary brain injury. First, basic maneuvers such as head-of-bed elevation and neutral neck positioning maximize venous outflow. Second, when basic measures and sedation fail, hyperosmolar therapy (hypertonic saline or mannitol) is administered to osmotically reduce brain volume. Third, if ICP remains refractory, mild hyperventilation can be used to induce cerebral vasoconstriction, though it is delayed due to the risk of causing cerebral ischemia. Finally, decompressive craniectomy is reserved as a surgical salvage therapy for medically refractory intracranial hypertension.

Adım Adım Çözüm

1
Implement basic physiological measures.
Head of bed elevated and neck aligned.
Optimizes jugular venous outflow and decreases ICP with minimal risk.
2
Administer hyperosmolar therapy.
Hypertonic saline is given.
Creates an osmotic gradient to reduce cerebral edema; represents the standard first-line medical therapy for elevated ICP.
3
Utilize short-term hyperventilation.
Target PaCO 2_2 reduced to 30-35 mm Hg.
Induces cerebral vasoconstriction for rapid ICP reduction, but used cautiously and later in the algorithm due to the risk of ischemia.
4
Proceed to surgical decompression.
Decompressive craniectomy is performed.
Serves as a definitive salvage therapy for refractory intracranial hypertension.

Anahtar Kavram

The stepwise management of elevated intracranial pressure involves a tiered approach, starting with basic physiological optimization, progressing to medical interventions (osmolar therapy, hyperventilation), and ending with salvage surgical procedures.
Soru 4165Soru →

A 58-year-old man arrives at the emergency department reporting the sudden onset of agonizing, "tearing" chest pain that radiates to his back between his shoulder blades. He appears diaphoretic and in severe distress. Vital signs include a blood pressure of 195/115 mm Hg in the right arm and 145/90 mm Hg in the left arm, and a heart rate of 112/min. A new early diastolic murmur is auscultated at the right sternal border. Electrocardiography demonstrates sinus tachycardia without acute ischemic changes. A portable chest radiograph reveals a widened mediastinum.

Arrange the following management steps in the most appropriate sequential order for this patient.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence is: 1) Initiate an intravenous short-acting beta-blocker infusion, 2) Administer an intravenous titratable vasodilator, 3) Perform computed tomography angiography of the aorta, 4) Transfer for emergent ascending aortic replacement.
The management of a suspected acute aortic dissection follows a strict sequence prioritizing the reduction of aortic wall shear stress (anti-impulse therapy) to prevent catastrophic rupture. The sequence must begin with a short-acting intravenous beta-blocker (e.g., esmolol or labetalol) to reduce heart rate and left ventricular contractility. Only after adequate beta-blockade is achieved should a titratable intravenous vasodilator (e.g., nitroprusside) be added to strictly control systolic blood pressure (target 100-120 mm Hg). Once hemodynamics are controlled, the patient is stabilized enough to safely undergo computed tomography angiography to confirm the diagnosis and delineate the dissection's anatomy. Finally, because this patient exhibits signs of ascending aortic involvement (Stanford Type A)—evidenced by the new early diastolic murmur of aortic regurgitation—emergent surgical replacement of the ascending aorta is the definitive life-saving intervention.

Adım Adım Çözüm

1
Identify the suspected diagnosis based on the clinical presentation.
The patient's sudden, tearing chest pain, asymmetric blood pressures, widened mediastinum, and new aortic regurgitation murmur strongly suggest an acute aortic dissection involving the ascending aorta.
Recognizing the high probability of aortic dissection dictates the immediate need to prevent aortic rupture and dissection propagation before leaving the emergency department.
2
Determine the immediate medical resuscitation priorities prior to diagnostic confirmation.
Anti-impulse therapy must be initiated immediately to reduce aortic wall shear stress. This strictly begins with intravenous beta-blockade (e.g., esmolol) to lower the heart rate and myocardial contractility.
Decreasing left ventricular contractility (dP/dt) minimizes the shearing forces on the initial intimal tear. Beta-blockade must be established as the absolute first step in medical management.
3
Determine the second step in medical management.
Intravenous vasodilators (e.g., nitroprusside or nicardipine) are added to lower the systolic blood pressure to a strict target of 100-120 mm Hg.
Vasodilators are necessary to control severe hypertension, but if given before beta-blockers, they cause reflex tachycardia and increased contractility, which can rapidly worsen the dissection.
4
Determine the appropriate timing for diagnostic imaging.
Computed tomography angiography is performed after the patient's heart rate and blood pressure are strictly controlled.
Moving a highly hypertensive, tachycardic patient to the scanner without anti-impulse therapy risks sudden aortic rupture during transport or while in the CT scanner.
5
Determine the definitive treatment based on the suspected extent.
Emergent surgical repair via median sternotomy.
Dissections involving the ascending aorta (Stanford Type A) are absolute surgical emergencies due to the high risk of fatal complications, including cardiac tamponade, aortic valve disruption, or coronary artery occlusion.

Anahtar Kavram

The precise sequential management of acute aortic dissection.
Tahmini Süre:1m 30s
Soru 4166Soru →

A 28-year-old primigravida presents for her first prenatal visit at 10 weeks of gestation. She recently immigrated from an area with high endemicity for hepatitis B. Arrange the following clinical preventive, diagnostic, and surveillance steps in the correct chronological order to appropriately screen, evaluate, and manage this patient and her future offspring to minimize vertical transmission.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct chronological sequence is: 1) Maternal HBsAg screening at the first prenatal visit, 2) Quantification of maternal HBV DNA and HBeAg, 3) Initiation of maternal tenofovir prophylaxis in the third trimester if indicated, 4) Administration of the HBV vaccine and HBIG to the newborn within 12 hours of birth, and 5) Infant post-vaccination serologic testing at 9 to 12 months of age.
The correct sequence mirrors the standard clinical pathway for preventing vertical transmission of Hepatitis B. It begins with population-level screening (HBsAg), followed by risk stratification via viral load quantification (HBV DNA). High-risk mothers receive targeted third-trimester antiviral therapy (tenofovir) to lower viremia. At delivery, the neonate receives immediate post-exposure prophylaxis (vaccine and HBIG). Finally, the success of these interventions is confirmed via serologic surveillance at 9 to 12 months, allowing sufficient time for the infant's endogenous immune response to develop and for exogenous HBIG to wane.

Adım Adım Çözüm

1
Perform universal maternal HBsAg screening.
Identifies maternal HBV infection status early in pregnancy.
Required by USPSTF to identify pregnancies at high risk for perinatal HBV transmission, setting the cascade in motion.
2
Measure maternal HBV DNA and HBeAg.
Determines the level of maternal viremia and relative infectivity.
A high viral load (>200,000 IU/mL) indicates a significant risk of immunoprophylaxis failure at birth, necessitating additional prenatal interventions.
3
Administer maternal antiviral therapy at 28-32 weeks.
Reduces maternal viral load prior to the onset of labor.
Minimizes the risk of fetal exposure to high levels of the virus during the birthing process when maternal-fetal blood mixing occurs.
4
Give HBIG and HBV vaccine to the neonate within 12 hours of birth.
Provides immediate passive and active immunity to the neonate.
Highly effective at preventing chronic HBV infection when administered immediately following delivery.
5
Check infant HBsAg and anti-HBs at 9-12 months.
Confirms the infant is protected (anti-HBs positive) and not infected (HBsAg negative).
Testing before 9 months may yield false-positive anti-HBs results due to the passively transferred HBIG administered at birth.

Anahtar Kavram

Prevention of Perinatal Hepatitis B Transmission
Tahmini Süre:1m 30s
Soru 4167Soru →

A 48-year-old woman presents to the clinic with progressive weight gain, facial plethora, and easy bruising over the past year. Examination reveals central adiposity, prominent violaceous abdominal striae, and proximal muscle weakness. Her blood pressure is 155/95155/95 mmHg. Initial basic metabolic panel reveals mild hypokalemia. Arrange the following diagnostic and management steps in the most appropriate chronological sequence for this patient.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence is: confirm hypercortisolism (urine free cortisol), determine ACTH dependence (plasma ACTH), localize the lesion (abdominal CT), perform definitive treatment (laparoscopic adrenalectomy), and manage adrenal suppression (postoperative glucocorticoid taper).
The diagnostic and surgical management of Cushing syndrome follows a strict algorithm to avoid diagnostic errors and perioperative morbidity. Step 1 is establishing the presence of hypercortisolism (e.g., 24-hour urine free cortisol). Step 2 is measuring ACTH to determine the source; suppressed ACTH indicates a primary adrenal issue. Step 3 is anatomical localization using an abdominal CT scan, which is only performed once biochemical evidence points to the adrenals. Step 4 is the definitive surgical resection (laparoscopic adrenalectomy). Step 5 is the critical postoperative initiation of a glucocorticoid taper to prevent acute adrenal insufficiency due to chronic suppression of the contralateral gland.

Adım Adım Çözüm

1
Recognize the clinical presentation of Cushing syndrome.
Suspect endogenous hypercortisolism based on striae, central obesity, hypertension, and proximal weakness.
Clinical suspicion dictates the initiation of an endocrine workup rather than immediate imaging.
2
Select a primary screening test for hypercortisolism.
Order a 24-hour urine free cortisol, late-night salivary cortisol, or low-dose dexamethasone suppression test.
Hypercortisolism must be biochemically confirmed before localizing the source.
3
Determine the etiology by measuring ACTH.
Measure plasma ACTH level to identify if the process is ACTH-dependent or ACTH-independent.
A suppressed ACTH level points to an autonomous adrenal source, guiding the choice of anatomical imaging.
4
Localize the specific lesion.
Perform a CT scan of the abdomen.
Once an adrenal source is confirmed biochemically, imaging is used strictly for surgical planning.
5
Perform surgical intervention.
Execute a unilateral laparoscopic adrenalectomy.
Resection of the hyperfunctioning adenoma is the definitive treatment.
6
Provide crucial postoperative medical management.
Administer a tapering dose of glucocorticoids over several months.
The contralateral adrenal gland is suppressed by chronic hypercortisolism and cannot immediately produce sufficient cortisol, risking an acute adrenal crisis.

Anahtar Kavram

Algorithm for evaluation and surgical management of primary hypercortisolism (Cushing syndrome due to adrenal adenoma).
Tahmini Süre:1m 30s
Soru 4168Soru →

Match the following clinical presentations of urologic pathology with their most appropriate definitive surgical management.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 15-year-old boy presents with a 4-hour history of sudden-onset, severe unilateral scrotal pain, nausea, and an absent cremasteric reflex.
A 65-year-old man presents with recurrent urinary retention and failure of dual medical therapy for benign prostatic hyperplasia.
A 58-year-old man is found to have an incidental 3-cm solid, enhancing mass in the lower pole of the right kidney.
A 70-year-old man with painless gross hematuria undergoes cystoscopy, which reveals a 2-cm superficial papillary lesion.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

Testicular torsion requires bilateral orchiopexy; refractory BPH requires TURP; a small renal mass requires partial nephrectomy; and a superficial bladder tumor requires TURBT.
The correct matches align each clinical presentation with its evidence-based, gold-standard surgical intervention as outlined by urological guidelines. Testicular torsion is a surgical emergency necessitating immediate bilateral orchiopexy. Refractory BPH with complications requires TURP. A small renal mass (clinical stage T1a) warrants a nephron-sparing partial nephrectomy. A superficial bladder tumor is diagnosed and treated initially with a TURBT.

Adım Adım Çözüm

1
Analyze the first presentation: 15-year-old boy with sudden scrotal pain and absent cremasteric reflex.
Identify as testicular torsion.
These findings are highly specific for ischemia of the testicle, a surgical emergency.
2
Analyze the second presentation: 65-year-old man with BPH refractory to medical therapy.
Identify the need for surgical removal of obstructing prostate tissue.
Failed medical management and recurrent retention are absolute indications for surgical intervention.
3
Analyze the third presentation: 58-year-old man with a 3-cm renal mass.
Identify as a presumed stage T1a renal cell carcinoma.
Enhancing renal masses under 4 cm should be managed with nephron-sparing surgery to preserve renal function.
4
Analyze the fourth presentation: 70-year-old man with a superficial bladder tumor.
Identify as non-muscle invasive bladder cancer.
Initial management requires endoscopic resection to evaluate the depth of invasion and remove the visible tumor.

Anahtar Kavram

Definitive surgical management of common urologic conditions (torsion, BPH, renal cell carcinoma, and bladder cancer)
Soru 4169Soru →

A public health team conducts a large prospective cohort study to investigate the association between a novel airborne industrial chemical exposure and the development of adult-onset asthma. The unadjusted (crude) analysis reveals a relative risk (RR) of 3.23.2 (95% CI: 2.4−4.12.4 - 4.1, p<0.001p < 0.001) for asthma in exposed workers compared to unexposed workers.

Concerned about potential extraneous variables, the researchers stratify the data by a history of tobacco smoking. The stratified analysis yields the following results:

Smoking StatusRelative Risk (RR)95% Confidence Intervalp-value
Smokers1.30.9 - 1.80.18
Non-smokers1.20.8 - 1.70.22

The lead investigator reviews the data, noting that the 95% confidence intervals in the stratified groups cross 1.01.0 and overlap with each other. Based on these statistical findings, the investigator concludes that smoking is an effect modifier and that the airborne chemical exposure does not have a true independent association with asthma.

Which of the following is the most accurate statistical critique of the study's findings and the investigator's conclusion?

Cevabı ve açıklamayı göster

Cevap: The conclusion is incorrect; the data demonstrates that smoking is a confounding variable, as the stratum-specific relative risks are similar to each other but differ significantly from the crude relative risk.

Cevap

The data demonstrates that smoking is a confounding variable, as the stratum-specific relative risks are similar to each other but differ significantly from the crude relative risk.
In epidemiological and statistical analysis, stratification is a key method for distinguishing between confounding and effect modification. The crude analysis showed a strong relative risk of 3.2. When the data was stratified by smoking status, the relative risk in both groups plummeted to approximately 1.2 and 1.3. Because the stratum-specific estimates are similar to each other but significantly different from the crude estimate, smoking is acting as a confounding variable. The investigator's conclusion that smoking is an effect modifier is statistically incorrect; effect modification requires the effect size to differ meaningfully between the strata.

Adım Adım Çözüm

1
Analyze the crude statistical findings.
The unadjusted relative risk is 3.2 (95% CI: 2.4 - 4.1), indicating a strong, statistically significant association between chemical exposure and asthma.
Establishing the baseline association is necessary before evaluating the impact of stratification.
2
Evaluate the stratum-specific point estimates.
In smokers, the RR is 1.3. In non-smokers, the RR is 1.2.
Comparing the magnitude of the effect across different strata reveals how the third variable influences the relationship.
3
Differentiate between confounding and effect modification based on the point estimates.
The stratum-specific RRs (1.2 and 1.3) are similar to each other but notably different from the crude RR (3.2). This statistical pattern defines confounding.
If the strata were significantly different from each other (e.g., 1.2 vs 5.5), it would indicate effect modification. Since they are nearly identical but lower than the crude, smoking is a confounder artificially inflating the initial unadjusted result.

Anahtar Kavram

Confounding vs. Effect Modification via Stratification
Tahmini Süre:2m 0s
Soru 4170Soru →

An antimicrobial stewardship committee at a tertiary care center is designing a new workflow for the expedited administration of empiric antibiotics in the emergency department. Before implementing the protocol, a multidisciplinary team prospectively maps out every step of the proposed process. They identify a potential vulnerability: a patient with unrecognized acute kidney injury could mistakenly receive an unadjusted dose of a renally cleared, broad-spectrum antibiotic. The team assigns numerical values (from 11 to 1010) representing the likelihood of this error, the severity of potential patient harm, and the probability that the error will remain undetected before administration. Multiplying these three values yields a specific numerical metric. Which of the following best describes the primary purpose of calculating this metric in this quality improvement framework?

Cevabı ve açıklamayı göster

Cevap: To prioritize which identified vulnerabilities require the most urgent implementation of forcing functions or system redesigns

Cevap

To prioritize which identified vulnerabilities require the most urgent implementation of forcing functions or system redesigns
The quality improvement framework described in the vignette is Failure Mode and Effects Analysis (FMEA). FMEA is a prospective, proactive systems-engineering approach used to identify and mitigate potential vulnerabilities before a new process is implemented and before they reach the patient. During an FMEA, a multidisciplinary team maps out a process and identifies potential failure modes. For each failure mode, the team assigns a numerical score (typically 11 to 1010) for three variables: Severity (how much harm would occur), Occurrence (how likely it is to happen), and Detection (the probability it will not be caught before reaching the patient). The product of these three scores is the Risk Priority Number (RPNRPN). The primary purpose of calculating the RPNRPN is to objectively rank and prioritize which failure modes pose the greatest overall risk to patient safety. This directs leadership and safety committees on where to allocate resources most urgently to implement effective interventions, such as forcing functions or system redesigns.

Adım Adım Çözüm

1
Identify the quality improvement methodology being described in the vignette.
The team is prospectively mapping a process and scoring potential failures based on likelihood, severity, and detectability, which defines Failure Mode and Effects Analysis (FMEA).
Recognizing the framework distinguishes it from retrospective tools like RCA or iterative testing like PDSA.
2
Identify the specific numerical metric being calculated.
The metric is the Risk Priority Number (RPNRPN), calculated as RPN=Occurrence×Severity×DetectionRPN = Occurrence \times Severity \times Detection.
Understanding the formula clarifies the purpose of the data collection in the scenario.
3
Determine the clinical utility of the RPN in an FMEA.
The RPNRPN objectively ranks the identified failure modes.
Higher RPNRPN values indicate greater overall risk, directing the institution on where to allocate resources first for system redesigns to proactively prevent patient harm.

Anahtar Kavram

Failure Mode and Effects Analysis (FMEA) and Risk Priority Number (RPN)
Tahmini Süre:1m 30s
Soru 4171Soru →

A team of clinical researchers is investigating a novel salivary biomarker for the detection of oral squamous cell carcinoma. They conduct an initial validation study in a high-risk cohort consisting exclusively of patients with chronic heavy tobacco and alcohol use. In this specific cohort, the prevalence of the cancer is 50%50\%. Analysis of the study data reveals that the positive predictive value of the biomarker test is 90%90\%.

Following these promising results, the researchers propose implementing this biomarker as a routine screening tool in a general community dental practice, where the prevalence of oral squamous cell carcinoma is 10%10\%. The sensitivity and specificity of the assay are intrinsic properties of the test and remain constant across both populations.

What is the expected positive predictive value of this biomarker test when used in the general community dental practice?

Cevabı ve açıklamayı göster

Cevap: 50%

Cevap

The expected positive predictive value of the biomarker test in the general community dental practice is 50%.
The positive predictive value (PPV) is heavily dependent on the prevalence of the disease in the tested population. When prevalence decreases, PPV decreases. To calculate the exact new PPV, one can use odds and likelihood ratios (LR). In the 50%50\% prevalence cohort, the pre-test probability is 0.50.5, meaning pre-test odds are 1:11:1 (or 11). The PPV (post-test probability) is 90%90\%, so the post-test odds are 0.9/0.1=90.9 / 0.1 = 9. Because Post-test Odds = Pre-test Odds ×\times LR+, the LR+ for this biomarker is 99.

In the new community practice, the prevalence (pre-test probability) is 10%10\%, giving pre-test odds of 0.1/0.9=1/90.1 / 0.9 = 1/9. Using the test's fixed LR+ of 99, the new post-test odds are (1/9)×9=1(1/9) \times 9 = 1. Converting odds back to probability (Odds / (11 + Odds)), the new PPV is 1/(1+1)=0.51 / (1 + 1) = 0.5, or 50%50\%.

Alternatively, this can be proven using hypothetical values that fit the initial constraints. If sensitivity and specificity are both 90%90\%, a population of 10001000 with 50%50\% prevalence has 500500 diseased (450450 True Positives) and 500500 healthy (5050 False Positives), yielding a PPV of 450/(450+50)=90%450/(450+50) = 90\%. Applying these same parameters to a 10%10\% prevalence population yields 100100 diseased (9090 True Positives) and 900900 healthy (9090 False Positives). The new PPV is 90/(90+90)=50%90/(90+90) = 50\%.

Adım Adım Çözüm

1
Determine the Positive Likelihood Ratio (LR+) of the test from the initial high-risk cohort data.
In the high-risk cohort (50%50\% prevalence), the pre-test odds are 1:11:1 (or 11). With a PPV of 90%90\%, the post-test odds are 0.9/0.1=90.9 / 0.1 = 9. Since Post-test Odds = Pre-test Odds ×\times LR+, the LR+ must be 9/1=99 / 1 = 9.
Extracting the test's inherent diagnostic performance (LR+) allows us to mathematically apply it to a population with a different prevalence.
2
Calculate the new pre-test odds and post-test odds for the general community dental practice.
The new prevalence is 10%10\%, meaning the pre-test odds are 10%/90%=1/910\% / 90\% = 1/9. Post-test Odds = Pre-test Odds ×\times LR+ = (1/9)×9=1(1/9) \times 9 = 1.
This determines the odds that a patient with a positive test in the new, lower-prevalence population actually has the disease.
3
Convert the post-test odds back to a probability to find the new Positive Predictive Value.
Probability = Odds / (11 + Odds) = 1/(1+1)=0.51 / (1 + 1) = 0.5, or 50%50\%.
The question asks for the expected PPV (a probability, not an odds ratio), which calculates out to 50%50\%.

Anahtar Kavram

The relationship between disease prevalence, likelihood ratios, and predictive values (Bayes' Theorem).
Soru 4172Soru →

A 42-year-old man visits a new primary care physician for a general health check-up. He reports feeling well and has no chronic medical conditions. His social history is notable for occasional alcohol consumption and a period of injection drug use during his early twenties. Physical examination shows no abnormalities. The physician initiates universal screening for an infectious disease that the patient is at high risk for. Arrange the following clinical steps in the most appropriate chronological order for the screening, diagnosis, and management of Hepatitis C virus (HCV) infection for this patient.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence begins with the HCV antibody screening test, followed by quantitative HCV RNA PCR to confirm active infection, noninvasive fibrosis staging to guide management, initiation of DAA therapy, and finally assessing for sustained virologic response (SVR) 12 weeks post-treatment.
The standard clinical cascade for Hepatitis C virus (HCV) begins with an initial screening using an HCV antibody test, which identifies individuals who have ever been exposed to the virus. Because approximately 20% to 30% of acutely infected individuals spontaneously clear the virus, a positive antibody test must be followed by a quantitative HCV RNA PCR test to confirm the presence of active, ongoing infection. Once active viremia is confirmed, it is essential to evaluate the patient for underlying liver damage before starting medication. Noninvasive fibrosis staging methods, such as the FIB-4 index or transient elastography, are used to determine if cirrhosis is present, which critically influences the specific drug regimen, treatment duration, and the need for future hepatocellular carcinoma screening. After the patient's liver status is staged, a regimen of direct-acting antivirals (DAAs) is prescribed. Finally, the efficacy of the treatment is evaluated by checking the HCV RNA level exactly 12 weeks after the completion of the DAA course; an undetectable viral load at this time indicates a sustained virologic response (SVR), equating to a clinical cure.

Adım Adım Çözüm

1
Identify the appropriate initial screening test for Hepatitis C.
HCV antibody enzyme immunoassay is selected.
Current guidelines recommend universal screening for adults aged 18-79 years for HCV infection using an anti-HCV antibody test.
2
Determine the necessary confirmatory test for a positive screening result.
Quantitative HCV RNA PCR is selected.
A positive antibody test cannot distinguish between active infection and spontaneous clearance; HCV RNA testing is definitively required to confirm active viremia.
3
Identify the required pre-treatment evaluation.
Noninvasive fibrosis staging (e.g., FIB-4 or transient elastography) is selected.
Before initiating any treatment, the degree of liver fibrosis must be assessed to rule out cirrhosis and accurately guide the choice and duration of therapy.
4
Select the therapeutic intervention.
Direct-acting antiviral (DAA) therapy is initiated.
Once active infection is confirmed and fibrosis is clinically staged, highly effective DAA therapy is the standard of care to eradicate the virus.
5
Determine the appropriate method to confirm treatment success.
HCV RNA is measured 12 weeks post-treatment.
Sustained virologic response (SVR), defined as completely undetectable HCV RNA 12 weeks after completing DAA therapy, confirms a definitive virologic cure.

Anahtar Kavram

The stepwise diagnostic and therapeutic cascade for Hepatitis C virus (HCV) includes sequential antibody screening, RNA confirmation, fibrosis staging, DAA treatment, and post-treatment SVR evaluation.
Soru 4173Soru →

A 65-year-old man is brought to the emergency department unconscious following an ischemic stroke. He requires urgent medical intervention. The patient lacks decision-making capacity and has no written advance directive or formally designated healthcare proxy. Several family members arrive at the hospital and all want to participate in his care decisions. According to standard legal precedence in the United States, arrange the following family members in the correct hierarchy of priority to act as the surrogate decision-maker, from highest priority (first) to lowest priority (last).

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct order of surrogate decision-maker priority is: Wife (Spouse), 30-year-old daughter (Adult Child), 85-year-old father (Parent), and 60-year-old brother (Adult Sibling).
In the absence of an advance directive or designated healthcare proxy, substitute decision-making falls to a surrogate according to a standard legal hierarchy. The universally accepted standard sequence in the United States is: Spouse, followed by Adult Children, then Parents, and finally Adult Siblings. Therefore, the wife has first priority, the 30-year-old daughter is second, the 85-year-old father is third, and the 60-year-old brother is fourth.

Adım Adım Çözüm

1
Determine if the patient has capacity or a designated proxy.
The patient lacks capacity and has no advance directive or designated proxy.
This triggers the need for a default statutory surrogate decision-maker.
2
Recall the standard statutory hierarchy for surrogate decision-makers.
The standard hierarchy is: 1. Spouse, 2. Adult Children, 3. Parents, 4. Adult Siblings, 5. Other relatives.
This legal hierarchy exists to prevent conflicts and ensure decisions are made by those presumed closest to the patient.
3
Match the family members provided in the scenario to the established hierarchy.
Wife = 1, Daughter = 2, Father = 3, Brother = 4.
Applying the concept to the specific options yields the correct sequence.

Anahtar Kavram

Statutory surrogate decision-maker hierarchy
Tahmini Süre:1m 0s
Soru 4174Soru →

A 15-month-old girl is brought to the clinic for a delayed well-child visit. Her parents report she missed her 12-month appointment due to scheduling conflicts. Her past medical history is significant for severe persistent asthma. Three weeks ago, she was hospitalized for a severe asthma exacerbation and was discharged on a 4-week taper of oral prednisone, initially at 22 mg/kg/day. She is currently on day 21 of the taper, taking 1.51.5 mg/kg/day. Environmental history reveals no household exposure to secondhand smoke (0 pack-years). Family history is notable for asthma in her mother and colon cancer in her paternal grandfather. Current vital signs are temperature 37.1°C (98.8°F), pulse 110/min, and respirations 24/min. Physical examination shows an active, well-appearing child with clear lungs. Her immunization record indicates she received all recommended doses at her 2-, 4-, and 6-month visits. In addition to catch-up doses of Haemophilus influenzae type b (Hib) and pneumococcal conjugate vaccines, which of the following is the most appropriate next step regarding this patient's routine immunizations?

Cevabı ve açıklamayı göster

Cevap: Administer the inactivated influenza vaccine today and defer the measles, mumps, and rubella (MMR) and varicella vaccines

Cevap

The most appropriate action is to administer the inactivated influenza vaccine today and defer live-attenuated vaccines (MMR and varicella) until the immune system recovers.
This patient is currently receiving high-dose systemic corticosteroids, defined as a daily dose of ≥2\geq 2 mg/kg or ≥20\geq 20 mg of prednisone (or equivalent) for ≥14\geq 14 consecutive days. This prolonged regimen causes significant iatrogenic cellular immunosuppression. In such immunocompromised states, the administration of live-attenuated vaccines can lead to unchecked viral replication and severe, potentially fatal vaccine-strain infections. Therefore, live vaccines normally scheduled at 12 to 15 months, including the measles, mumps, and rubella (MMR) and varicella vaccines, must be deferred until the immune system recovers (typically at least one month after discontinuing the high-dose steroids). However, inactivated vaccines, such as the injectable formulation of the influenza vaccine, pose no risk of systemic infection and should be administered according to the normal catch-up schedule.

Adım Adım Çözüm

1
Identify the patient's current medication status and its immunological effect.
The patient is on day 21 of a corticosteroid taper that began at 22 mg/kg/day.
High-dose systemic corticosteroids (≥2\geq 2 mg/kg/day or ≥20\geq 20 mg/day of prednisone for ≥14\geq 14 days) cause profound iatrogenic cellular immunosuppression.
2
Determine the patient's immunization needs.
The patient is missing her 12-month routine vaccines, which classically include the live-attenuated MMR and varicella vaccines, as well as seasonal influenza.
To provide necessary preventive care without causing harm.
3
Apply general immunization guidelines for immunocompromised hosts.
Live-attenuated vaccines must be deferred, while inactivated vaccines are safe to administer.
Live vaccines can cause disseminated vaccine-strain infection in patients lacking sufficient cellular immunity.

Anahtar Kavram

Administration of live-attenuated vaccines is strictly contraindicated in patients receiving high-dose systemic corticosteroids due to the risk of unchecked viral replication.
Soru 4175Soru →

An 8-week-old male infant presents to a primary care clinic with his parents to establish care and receive standard immunizations. He was diagnosed with severe combined immunodeficiency shortly after birth due to an abnormal newborn screening result. The patient is currently asymptomatic, feeding well, and gaining weight appropriately. He is on prophylactic antimicrobial therapy and is scheduled for a hematopoietic stem cell transplant in the coming months. The parents ask the physician how his diagnosis affects his vaccination schedule today. Which of the following is the most appropriate immunization strategy for this patient at this visit?

Cevabı ve açıklamayı göster

Cevap: Withhold the oral rotavirus vaccine but administer the scheduled inactivated formulations

Cevap

Withhold the oral rotavirus vaccine but administer the scheduled inactivated formulations
The patient has severe combined immunodeficiency (SCID), characterized by profound defects in T-cell function. In such patients, live-attenuated vaccines can replicate unchecked and cause severe, life-threatening vaccine-strain infections. The oral rotavirus vaccine is a live-attenuated viral vaccine and is therefore absolutely contraindicated. Conversely, inactivated, recombinant, and toxoid-based vaccines cannot replicate and are considered safe. These should be administered according to the routine schedule to provide whatever degree of immunity the patient can generate prior to transplantation.

Adım Adım Çözüm

1
Identify the patient's underlying condition and immune status.
The patient has severe combined immunodeficiency (SCID), which involves profound T-cell deficiency.
Immune status directly dictates the safety profile of live-attenuated vaccines.
2
Evaluate the standard 2-month (8-week) immunization schedule.
Standard vaccines at this age include rotavirus (live-attenuated), and several inactivated or recombinant vaccines (hepatitis B, DTaP, Hib, pneumococcal conjugate, IPV).
To determine which specific scheduled vaccines are indicated or contraindicated.
3
Apply contraindication rules for severely immunocompromised patients.
Live vaccines (rotavirus) must be withheld, while all inactivated vaccines should be administered on schedule.
Live vaccines can cause fatal infections in SCID, whereas inactivated vaccines pose no infectious risk.

Anahtar Kavram

Live-attenuated vaccines are absolutely contraindicated in patients with severe cellular immunodeficiencies.
Soru 4176Soru →

Investigators conduct an observational cohort study to evaluate the association between the use of a novel oral contraceptive pill (OCP) and the incidence of deep vein thrombosis (DVT). The initial crude analysis demonstrates a relative risk (RR) of 3.23.2 (95%95\% CI: 2.12.1-4.84.8) for DVT in OCP users compared to non-users. The researchers then stratify the data by smoking status. In the stratified analysis, the RR for DVT is 1.11.1 (95%95\% CI: 0.80.8-1.51.5) among smokers and 1.21.2 (95%95\% CI: 0.90.9-1.61.6) among non-smokers.

Which of the following statements are correct regarding the role of smoking status and the appropriate epidemiological methods to address it? (Select 2 answers)

Geçerli olan tümünü seçin

Cevabı ve açıklamayı göster

Cevap: Smoking acts as a confounding variable because the stratum-specific risk estimates are similar to each other but differ significantly from the crude estimate.; Multivariable regression analysis could be utilized during the data evaluation phase to appropriately adjust for the effects of smoking.

Cevap

The correct statements are that smoking acts as a confounding variable (because stratum-specific estimates are similar to each other but different from the crude) and that multivariable regression is an appropriate analysis-phase method to adjust for it.
The data demonstrates confounding because stratifying by smoking status eliminates the apparent strong association seen in the crude analysis, yielding stratum-specific relative risks (1.11.1 and 1.21.2) that are similar to each other but different from the crude relative risk (3.23.2). Furthermore, multivariable regression is a standard analytical method used after data collection to adjust for identified confounders like smoking.

Adım Adım Çözüm

1
Compare the unadjusted (crude) relative risk to the stratum-specific relative risks.
The crude RR is 3.23.2. The stratified RRs are 1.11.1 (smokers) and 1.21.2 (non-smokers).
Comparing crude and stratified estimates is the primary method to distinguish between confounding and effect modification.
2
Determine the epidemiological role of the stratifying variable (smoking).
Because the stratified RRs (1.11.1 and 1.21.2) are similar to each other but differ significantly from the crude RR (3.23.2), smoking is a confounding variable.
Effect modification would result in stratum-specific RRs that differ significantly from each other.
3
Identify the appropriate stage and method to control for this variable.
Because confounding was identified, the researchers can use analysis-phase techniques like stratification (already done) or multivariable regression to adjust for it.
Methods like matching or restriction must be implemented during the design phase, before data collection.

Anahtar Kavram

Distinguishing confounding from effect modification and identifying appropriate methods to control for confounding at different study phases.
Soru 4177Soru →

A university health center is implementing a new point-of-care screening assay for a highly contagious viral pharyngitis during a campus outbreak. Epidemiological surveillance indicates that the prevalence of this specific viral infection among students presenting with a sore throat is 10%10\%. The manufacturer of the point-of-care assay reports a sensitivity of 90%90\% and a specificity of 90%90\%. A student presenting with a sore throat is tested using this new assay, and the result is positive.

Based on the provided test characteristics, which of the following best represents the probability that this student actually has the viral infection?

Cevabı ve açıklamayı göster

Cevap: 50%50\%

Cevap

50%50\%
The positive predictive value (PPV) is the probability that a patient with a positive test actually has the disease. It depends heavily on the prevalence of the disease in the tested population. Using a 2×22 \times 2 contingency table for a hypothetical cohort of 1,0001,000 students, a 10%10\% prevalence means 100100 students have the disease and 900900 do not. A test with 90%90\% sensitivity yields 9090 true positives (0.90×1000.90 \times 100). A test with 90%90\% specificity has a false positive rate of 10%10\%, which yields 9090 false positives (0.10×9000.10 \times 900). The total number of positive tests is 180180 (9090 true + 9090 false). The PPV is the ratio of true positives to total positives, which is 90/18090 / 180, resulting in 50%50\%.

Adım Adım Çözüm

1
Establish a hypothetical population to simplify calculations.
Assume a population of 1,0001,000 students presenting with a sore throat.
Using absolute numbers instead of pure probabilities makes calculating positive predictive value (PPV) more intuitive.
2
Calculate the true positives based on prevalence and sensitivity.
A prevalence of 10%10\% means 100100 students have the disease. A sensitivity of 90%90\% means there are 9090 true positive results (0.90×100=900.90 \times 100 = 90).
Sensitivity identifies the proportion of actually diseased individuals who test positive.
3
Calculate the false positives based on the healthy population and specificity.
900900 students do not have the disease. A specificity of 90%90\% means a 10%10\% false positive rate (1−0.90=0.101 - 0.90 = 0.10). Thus, there are 9090 false positive results (0.10×900=900.10 \times 900 = 90).
The false positive rate applied to the healthy individuals gives the number of people who incorrectly test positive.
4
Calculate the positive predictive value.
PPV=True PositivesTrue Positives+False Positives=9090+90=50%\text{PPV} = \frac{\text{True Positives}}{\text{True Positives} + \text{False Positives}} = \frac{90}{90 + 90} = 50\%.
PPV defines the probability that a positive test result represents a true infection.

Anahtar Kavram

Calculation of Positive Predictive Value (PPV) and the impact of disease prevalence on false positive rates.
Soru 4178Soru →

A prospective study evaluates the diagnostic performance of a rapid point-of-care synovial fluid assay for detecting septic arthritis. The study enrolls 1,0001,000 adult patients presenting to the emergency department with acute monoarticular joint effusions. All patients undergo both the rapid assay and a gold-standard synovial fluid culture. The culture confirms septic arthritis in 200200 patients. Among these confirmed cases, the rapid assay is positive in 180180 patients. Across the entire study cohort of 1,0001,000 patients, the rapid assay is positive in a total of 580580 patients. What is the negative likelihood ratio of this rapid assay? (Express your answer as a decimal).

Cevabı ve açıklamayı göster

Cevap: 0.2

Cevap

0.20
To find the negative likelihood ratio (LR−LR-), we must calculate the sensitivity and specificity from the study data. The study gives a gold-standard disease-positive population of 200200. Out of these, 180180 test positive, making the Sensitivity 180/200=0.90180/200 = 0.90. The remaining 800800 patients are disease-negative. Because the total number of positive tests is 580580, the number of false positives (positive test in a disease-negative patient) is 580−180=400580 - 180 = 400. The number of true negatives is therefore 800−400=400800 - 400 = 400. Specificity is 400/800=0.50400 / 800 = 0.50. The formula for LR−LR- is (1−Sensitivity)/Specificity(1 - \text{Sensitivity}) / \text{Specificity}. Substituting the values yields (1−0.90)/0.50=0.10/0.50=0.20(1 - 0.90) / 0.50 = 0.10 / 0.50 = 0.20.

Adım Adım Çözüm

1
Determine disease prevalence numbers from the total cohort.
Disease Positive = 200; Disease Negative = 800.
Establishing the absolute numbers for the presence and absence of the disease is required before calculating the true/false positive and negative rates.
2
Calculate the test Sensitivity.
Sensitivity = 180 / 200 = 0.90.
Sensitivity is the proportion of disease-positive individuals who correctly test positive (True Positives / Total Disease Positive).
3
Deduce False Positives (FP) and True Negatives (TN) to calculate Specificity.
FP = 580 - 180 = 400. TN = 800 - 400 = 400. Specificity = 400 / 800 = 0.50.
Because only the total number of positive tests (580) was given, subtracting the true positives (180) isolates the false positives. True negatives are the remainder of the disease-negative group.
4
Calculate the Negative Likelihood Ratio (LR−LR-).
LR−=(1−0.90)/0.50=0.20LR- = (1 - 0.90) / 0.50 = 0.20.
The negative likelihood ratio is calculated as the False Negative Rate divided by the True Negative Rate (Specificity), representing the probability of a negative test in a patient with the disease divided by the probability of a negative test in a patient without the disease.

Anahtar Kavram

The negative likelihood ratio (LR−LR-) is calculated as (1−Sensitivity)/Specificity(1 - \text{Sensitivity}) / \text{Specificity}. It requires extracting the true positive and false positive rates from clinical study totals.
Soru 4179Soru →

An emergency medical services team brings a 6262-year-old female to the hospital due to excruciating right-sided back pain, rigors, and altered mental status that began 2424 hours ago. Her medical history includes multiple previous episodes of kidney stones. She visited an outpatient clinic 4848 hours prior for pain on urination, where empirical oral nitrofurantoin was prescribed and a urine culture was obtained. Upon arrival today, vital signs show a temperature of 39.4∘C39.4^\circ\text{C} (102.9∘F102.9^\circ\text{F}), blood pressure of 85/55 mm Hg85/55\text{ mm Hg}, heart rate of 124/min124/\text{min}, and respiratory rate of 22/min22/\text{min}. Physical examination is notable for profound right costovertebral angle tenderness and dry mucous membranes. Blood tests indicate a leukocyte count of 22,000/mm322,000/\text{mm}^3. A non-contrast computed tomography scan reveals an 11-mm11\text{-mm} stone lodged in the proximal right ureter causing pronounced hydronephrosis. The outpatient clinic faxes her urine culture results, confirming an infection with Escherichia coli (>100,000 CFU/mL>100,000\text{ CFU/mL}). The organism is susceptible to ceftriaxone and ciprofloxacin, but resistant to ampicillin and nitrofurantoin. Rapid intravenous fluid resuscitation is commenced. Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Percutaneous nephrostomy and intravenous ceftriaxone

Cevap

Percutaneous nephrostomy and intravenous ceftriaxone
The correct answer combines urgent decompression with targeted antibiotic therapy. This patient presents with an infected, obstructing ureteral stone and resulting septic shock, which is a life-threatening urologic emergency. Immediate urinary tract decompression is mandatory to establish source control. This is typically achieved via percutaneous nephrostomy tube placement or retrograde ureteral stenting. Concurrently, antibiotic therapy must be optimized. Because the outpatient urine culture sensitivities are already available, transitioning to a targeted agent like intravenous ceftriaxone is indicated over maintaining broad-spectrum empiric coverage.

Adım Adım Çözüm

1
Identify the patient's primary clinical syndrome.
The patient is in septic shock secondary to an infected, obstructing right ureteral calculus.
Hypotension, tachycardia, fever, leukocytosis, and CT evidence of a proximal ureteral stone with hydronephrosis confirm the diagnosis.
2
Determine the necessary surgical intervention.
Immediate decompression of the urinary tract is required via percutaneous nephrostomy or retrograde ureteral stenting.
An obstructed, infected kidney is a closed space infection (urologic emergency) that cannot be sterilized with antibiotics alone. Definitive stone removal (e.g., ureteroscopy) is contraindicated during acute sepsis due to the risk of worsening shock.
3
Select the appropriate pharmacologic therapy based on the provided data.
Transition to intravenous ceftriaxone.
The urine culture results provide specific sensitivities. Good antibiotic stewardship requires using a targeted agent (ceftriaxone) rather than unnecessarily continuing broad-spectrum empiric antibiotics.

Anahtar Kavram

An infected, obstructing ureteral calculus requires emergent urinary tract decompression (via percutaneous nephrostomy or ureteral stent) combined with culture-directed targeted antibiotics.
Tahmini Süre:1m 15s
Soru 4180Soru →

Match each clinical exposure scenario with the most appropriate post-exposure prophylaxis strategy for an unimmunized or underimmunized patient.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

Unvaccinated healthcare worker with a needlestick injury from a patient positive for hepatitis B surface antigen.
Patient with an unknown immunization history presenting with a deep, soil-contaminated puncture wound.
Healthy, unvaccinated individual who awakens to find a bat in their bedroom, with no obvious bite marks.
Unvaccinated pregnant woman at 18 weeks gestation with a direct, prolonged exposure to a child with active chickenpox.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

Hepatitis B exposure requires HBIG and the HBV vaccine; severe dirty wounds with unknown history require TIG and Tdap/Td; indoor bat exposures require RIG and the Rabies vaccine; and Varicella exposure during pregnancy requires VZIG only.
Each correct pairing reflects the standard Centers for Disease Control and Prevention (CDC) guidelines for post-exposure prophylaxis in unimmunized patients. For significant exposures to Hepatitis B, Rabies, and Tetanus (via dirty wounds), the standard of care requires providing immediate passive immunity via disease-specific immune globulin, simultaneously paired with the initiation of the active vaccine series for long-term protection. For varicella exposure in a susceptible pregnant woman, only passive immunity is provided because the active vaccine is live-attenuated and strictly contraindicated during pregnancy.

Adım Adım Çözüm

1
Analyze the patient's baseline immune status and any contraindications.
All patients described lack prior immunity. The pregnant woman has an absolute contraindication to live vaccines.
Baseline immunity and physiologic state (like pregnancy) dictate whether active vaccination is safe and necessary.
2
Determine the necessity of passive immunity (immune globulin).
Immune globulin is indicated for all four scenarios.
Immediate circulating antibodies are required for high-risk exposures to Hep B, Rabies, Tetanus (in dirty wounds with unknown history), and Varicella (in high-risk susceptible hosts).
3
Determine the necessity and safety of active immunity (vaccination).
Vaccines are indicated for the Hep B, Tetanus, and Rabies exposures. The varicella vaccine is withheld.
Active immunization provides long-lasting protection and is standard for PEP protocols, except when a live vaccine is specifically contraindicated, as in pregnancy.

Anahtar Kavram

Post-Exposure Prophylaxis (PEP) protocols for unimmunized individuals and special populations
Tahmini Süre:1m 30s
ÖncekiSayfa 209 / 414Sonraki